Form 8-K - Current report:
SEC Accession No. 0000950170-25-093996
Filing Date
2025-07-03
Accepted
2025-07-03 17:22:35
Documents
10
Period of Report
2025-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K xene-20250630.htm   iXBRL 8-K 50460
  Complete submission text file 0000950170-25-093996.txt   163338

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20250630.xsd EX-101.SCH 30644
12 EXTRACTED XBRL INSTANCE DOCUMENT xene-20250630_htm.xml XML 4688
Mailing Address 200 - 3650 GILMORE WAY BURNABY British Columbia, Canada
Business Address 200 - 3650 GILMORE WAY BURNABY British Columbia, Canada (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 251106399
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)